GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 38 filers reported holding GT BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,513 | -23.3% | 10,424 | -0.7% | 0.00% | – |
| Q2 2023 | $3,276 | -43.3% | 10,500 | -0.1% | 0.00% | – |
| Q1 2023 | $5,779 | -38.1% | 10,507 | -0.4% | 0.00% | – |
| Q4 2022 | $9,340 | -78.8% | 10,545 | -57.9% | 0.00% | – |
| Q3 2022 | $44,000 | +37.5% | 25,034 | +135.0% | 0.00% | – |
| Q2 2022 | $32,000 | +3.2% | 10,652 | -0.2% | 0.00% | – |
| Q1 2022 | $31,000 | -85.7% | 10,677 | -85.0% | 0.00% | – |
| Q4 2021 | $217,000 | -38.5% | 71,234 | +35.9% | 0.00% | – |
| Q3 2021 | $353,000 | – | 52,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baskin Financial Services Inc. | 151,354 | $47 | 0.01% |
| McCollum Christoferson Group LLC | 17,500 | $5,460 | 0.00% |
| Moss Adams Wealth Advisors LLC | 10,000 | $3,120 | 0.00% |
| JANE STREET GROUP, LLC | 20,501 | $6,396 | 0.00% |
| Cubist Systematic Strategies, LLC | 10,458 | $3,263 | 0.00% |
| Point72 Asset Management, L.P. | 1 | $0 | 0.00% |
| UBS Group AG | 3,033 | $946 | 0.00% |
| Compagnie Lombard Odier SCmA | 50,000 | $15,600 | 0.00% |
| IFP Advisors, Inc | 100 | $275 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,017 | $316 | 0.00% |